Toll-like receptor 4 suppression leads to islet allograft survival

FASEB Journal

Volumn 21, Issue 11, 2007, Pages 2840-2848

  Goldberg, Alyssa ^a   Parolini, Margherita ^b   Chin, Beek Y ^a   Czismadia, Eva ^a   Otterbein, Leo E ^a   Bach, Fritz H ^a   Wang, Hongjun ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Carbon monoxide; Inflammation; Islet transplantation; Type 1 diabetes

Indexed keywords

CARBON MONOXIDE; HEME OXYGENASE 1; RECEPTOR ANTIBODY; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 4 ANTIBODY; UNCLASSIFIED DRUG;

ALLOGRAFT; ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GRAFT REJECTION; GRAFT SURVIVAL; MOUSE; NONHUMAN; PANCREAS ISLET CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ADENOVIRIDAE; ANIMALS; BLOTTING, WESTERN; CARBON MONOXIDE; DIABETES MELLITUS, EXPERIMENTAL; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNE TOLERANCE; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, KNOCKOUT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 4; TRANSPLANTATION, HOMOLOGOUS;

MUS;

EID: 34548516368     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.06-7910com     Document Type: Article

References (60)

1. Maines, M. D., Trakshel, G. M., and Kutty, R. K. (1986) Characterization of two constitutive forms of rat liver microsomal heme oxygenase. Only one molecular species of the enzyme is inducible. J. Biol. Chem. 261, 411-419
2. Rotenberg, M. O., and Maines, M. D. (1990) Isolation, characterization, and expression in Escherichia coli of a cDNA encoding rat heme oxygenase-2. J. Biol. Chem. 265, 7501-7506
3. McCoubrey, W. K., Jr., Huang, T. J., and Maines, M. D. (1997) Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur. J. Biochem. 247, 725-732
4. Durante, W., Kroll, M. H., Christodoulides, N., Peyton, K. J., and Schafer, A. I. (1997) Nitric oxide induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. Circ. Res. 80, 557-564
5. Terry, C. M., Clikeman, J. A., Hoidal, J. R., and Callahan, K. S. (1998) Effect of tumor necrosis factor-alpha and interleukin-1 alpha on heme oxygenase-1 expression in human endothelial cells. Am. J. Physiol. 274, H883-H891
6. Choi, A. M., and Alam, J. (1996) Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am. J. Respir. Cell Mol. Biol. 15, 9-19
7. Durante, W., Christodoulides, N., Cheng, K., Peyton, K. J., Sunahara, R. K., and Schafer, A. I. (1997) cAMP induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle. Am. J. Physiol. 273, H317-H323
8. Foresti, R., Clark, J. E., Green, C. J., and Motterlini, R. (1997) Thiol compounds interact with nitric oxide in regulating heme oxygenase-1 induction in endothelial cells. Involvement of superoxide and peroxynitrite anions. J. Biol. Chem. 272, 18411-18417
9. Kushida, T., Quan, S., Yang, L., Ikehara, S., Kappas, A., and Abraham, N. G. (2002) A significant role for the heme oxygenase-1 gene in endothelial cell cycle progression. Biochem. Biophys. Res. Commun. 291, 68-75
10. Alcaraz, M. J., Fernandez, P., and Guillen, M. I. (2003) Anti-inflammatory actions of the heme oxygenase-1 pathway. Curr. Pharm. Des. 9, 2541-2551
11. Yet, S. F., Pellacani, A., Patterson, C., Tan, L., Folta, S. C., Foster, L., Lee, W. S., Hsieh, C. M., and Perrella, M. A. (1997) Induction of heme oxygenase-1 expression in vascular smooth muscle cells. A link to endotoxic shock. J. Biol. Chem. 272, 4295-4301
12. Yang, L., Quan, S., and Abraham, N. G. (1999) Retrovirus-mediated HO gene transfer into endothelial cells protects against oxidant-induced injury. Am. J. Physiol. 277, L127-L133
13. Otterbein, L., Chin, B. Y., Otterbein, S. L., Lowe, V. C., Fessler, H. E., and Choi, A. M. (1997) Mechanism of hemoglobin-induced protection against endotoxemia in rats: a ferritinin-dependent pathway. Am. J. Physiol. 272, L268-L275
14. Otterbein, L. E., Kolls, J. K., Mantell, L. L., Cook, J. L., Alam, J., and Choi, A. M. (1999) Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury. J. Clin. Invest. 103, 1047-1054
15. Willis, D., Moore, A. R., Frederick, R., and Willoughby, D. A. (1996) Heme oxygenase: a novel target for the modulation of the inflammatory response. Nat. Med. 2, 87-90
16. Araujo, J. A., Meng, L., Tward, A. D., Hancock, W. W., Zhai, Y., Lee, A., Ishikawa, K., Iyer, S., Buelow, R., Busuttil, R. W., et al. (2003) Systemic rather than local heme oxygenase-1 overexpression improves cardiac allograft outcomes in a new transgenic mouse. J. Immunol. 171, 1572-1580
17. Katori, M., Busuttil, R. W., and Kupiec-Weglinski, J. W. (2002) Heme oxygenase-1 system in organ transplantation. Transplantation 74, 905-912
18. Amersi, F., Buelow, R., Kato, H., Ke, B., Coito, A. J., Shen, X. D., Zhao, D., Zaky, J., Melinek, J., Lassman, C. R., et al. (1999) Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. J. Clin. Invest. 104, 1631-1639
19. Woo, J., Iyer, S., Mori, N., and Buelow, R. (2000) Alleviation of graft-versus-host disease after conditioning with cobalt-protoporphyrin, an inducer of heme oxygenase-1. Transplantation 69, 623-633
20. Pileggi, A., Molano, R. D., Berney, T., Cattan, P., Vizzardelli, C., Oliver, R., Fraker, C., Ricordi, C., Pastori, R. L., Bach, F. H., and Inverardi, L. (2001) Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation. Diabetes 50, 1983-1991
21. Wang, H., Lee, S. S., Gao, W., Czismadia, E., McDaid, J., Ollinger, R., Soares, M. P., Yamashita, K., and Bach, F. H. (2005) Donor treatment with carbon monoxide can yield islet allograft survival and tolerance. Diabetes 54, 1400-1406
22. Pileggi, A., Molano, R. D., Berney, T., Ichii, H., San Jose, S., Zahr, E., Poggioli, R., Linetsky, E., Ricordi, C., and Inverardi, L. (2005) Prolonged allogeneic islet graft survival by protoporphyrins. Cell Transplant 14, 85-96
23. Wang, H., Lee, S. S., Dell'agnello, C., Tchipashvili, V., D'Avilla, J., Czismadia, E., Chin, B. Y., and Bach, F. H. (2006) Bilirubin can induce tolerance to islet allografts. Endocrinology 147, 762-768
24. Qureshi, S. T., Gros, P., and Malo, D. (1999) Host resistance to infection: genetic control of lipopolysaccharide responsiveness by TOLL-like receptor genes. Trends Genet. 15, 291-294
25. Vaidya, S. A., and Cheng, G. (2003) Toll-like receptors and innate antiviral responses. Curr. Opin. Immunol. 15, 402-407
26. O'Brien, G. C., Wang, J. H., and Redmond, H. P. (2005) Bacterial lipoprotein induces resistance to Gram-negative sepsis in TLR4-deficient mice via enhanced bacterial clearance. J. Immunol. 174, 1020-1026
27. Kawai, T., Adachi, O., Ogawa, T., Takeda, K., and Akira, S. (1999) Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11, 115-122
28. Bellocchio, S., Moretti, S., Perruccio, K., Fallarino, F., Bozza, S., Montagnoli, C., Mosci, P., Lipford, G. B., Pitzurra, L., and Romani, L. (2004) TLRs govern neutrophil activity in aspergillosis. J. Immunol. 173, 7406-7415
29. Li, X., Tupper, J. C., Bannerman, D. D., Winn, R. K., Rhodes, C. J., and Harlan, J. M. (2003) Phosphoinositide 3 kinase mediates Toll-like receptor 4-induced activation of NF-kappa B in endothelial cells. Infect. Immun. 71, 4414-4420
30. Beutler, B. (2004) Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430, 257-263
31. Zhou, J., An, H., Xu, H., Liu, S., and Cao, X. (2005) Heat shock up-regulates expression of Toll-like receptor-2 and Toll-like receptor-4 in human monocytes via p38 kinase signal pathway. Immunology 114, 522-530
32. Ohashi, K., Burkart, V., Flohe, S., and Kolb, H. (2000) Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J. Immunol. 164, 558-561
33. Okamura, Y., Watari, M., Jerud, E. S., Young, D. W., Ishizaka, S. T., Rose, J., Chow, J. C., and Strauss, J. F., 3rd (2001) The extra domain A of fibronectin activates Toll-like receptor 4. J. Biol. Chem. 276, 10229-10233
34. Weatherill, A. R., Lee, J. Y., Zhao, L., Lemay, D. G., Youn, H. S., and Hwang, D. H. (2005) Saturated and polyunsaturated fatty acids reciprocally modulate dendritic cell functions mediated through TLR4. J. Immunol. 174, 5390-5397
35. Goldstein, D. R., Tesar, B. M., Akira, S., and Lakkis, F. G. (2003) Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection. J. Clin. Invest. 111, 1571-1578
36. Matzinger, P. (1994) Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12, 991-1045
37. Oyama, J., Blais, C., Jr., Liu, X., Pu, M., Kobzik, L., Kelly, R. A., and Bourcier, T. (2004) Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice. Circulation 109, 784-789
38. Satoh, M., Nakamura, M., Akatsu, T., Shimoda, Y., Segawa, I., and Hiramori, K. (2004) Toll-like receptor 4 is expressed with enteroviral replication in myocardium from patients with dilated cardiomyopathy. Lab. Invest. 84, 173-181
39. Dunzendorfer, S., Lee, H. K., Soldau, K., and Tobias, P. S. (2004) Toll-like receptor 4 functions intracellularly in human coronary artery endothelial cells: roles of LBP and sCD14 in mediating LPS responses. FASEB J. 18, 1117-1119
40. Zhai, Y., Shen, X. D., O'Connell, R., Gao, F., Lassman, C., Busuttil, R. W., Cheng, G., and Kupiec-Weglinski, J. W. (2004) Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J. Immunol. 173, 7115-7119
41. Wassef, A., Janardhan, K., Pearce, J. W., and Singh, B. (2004) Toll-like receptor 4 in normal and inflamed lungs and other organs of pig, dog and cattle. Histol. Histopathol. 19, 1201-1208
42. Hollestelle, S. C., De Vries, M. R., Van Keulen, J. K., Schoneveld, A. H., Vink, A., Strijder, C. F., Van Middelaar, B. J., Pasterkamp, G., Quax, P. H., and De Kleijn, D. P. (2004) Toll-like receptor 4 is involved in outward arterial remodeling. Circulation 109, 393-398
43. Methe, H., Zimmer, E., Grimm, C., Nabauer, M., and Koglin, J. (2004) Evidence for a role of toll-like receptor 4 in development of chronic allograft rejection after cardiac transplantation. Transplantation 78, 1324-1331
44. Palmer, S. M., Burch, L. H., Mir, S., Smith, S. R., Kuo, P. C., Herczyk, W. F., Reinsmoen, N. L., and Schwartz, D. A. (2006) Donor polymorphisms in Toll-like receptor-4 influence the development of rejection after renal transplantation. Clin. Transplant. 20, 30-36
45. Thornley, T. B., Brehm, M. A., Markees, T. G., Shultz, L. D., Mordes, J. P., Welsh, R. M., Rossini, A. A., and Greiner, D. L. (2006) TLR agonists abrogate costimulation blockade-induced prolongation of skin allografts. J. Immunol. 176, 1561-1570
46. Vives-Pi, M., Somoza, N., Fernandez-Alvarez, J., Vargas, F., Caro, P., Alba, A., Gomis, R., Labeta, M. O., and Pujol-Borrell, R. (2003) Evidence of expression of endotoxin receptors CD14, toll-like receptors TLR4 and TLR2 and associated molecule MD-2 and of sensitivity to endotoxin (LPS) in islet beta cells. Clin. Exp. Immunol. 133, 208-218
47. Appelberg, R., Leal, I. S., Pais, T. F., Pedrosa, J., and Florido, M. (2000) Differences in resistance of C57BL/6 and C57BL/10 mice to infection by Mycobacterium avium are independent of gamma interferon. Infect. Immun. 68, 19-23
48. Ricordi, C., Gray, D. W., Hering, B. J., Kaufman, D. B., Warnock, G. L., Kneteman, N. M., Lake, S. P., London, N. J., Socci, C., Alejandro, R., et al. (1990) Islet isolation assessment in man and large animals. Acta Diabetol. Lat. 27, 185-195
49. Molano, R. D., Pileggi, A., Berney, T., Poggioli, R., Zahr, E., Oliver, R., Ricordi, C., Rothstein, D. M., Basadonna, G. P., and Inverardi, L. (2003) Prolonged islet allograft survival in diabetic NOD mice by targeting CD45RB and CD154. Diabetes 52, 957-964
50. Kumagai, N., O'Neil, J. J., Barth, R. N., LaMattina, J. C., Utsugi, R., Moran, S. G., Yamamoto, S., Vagefi, P. A., Kitamura, H., Kamano, C., Sachs, D. H., and Yamada, K. (2002) Vascularized islet-cell transplantation in miniature swine. I. Preparation of vascularized islet kidneys. Transplantation 74, 1223-1230
51. Gunther, L., Berberat, P. O., Haga, M., Brouard, S., Smith, R. N., Soares, M. P., Bach, F. H., and Tobiasch, E. (2002) Carbon monoxide protects pancreatic beta-cells from apoptosis and improves islet function/survival after transplantation. Diabetes 51, 994-999
52. Poltorak, A., Merlin, T., Nielsen, P. J., Sandra, O., Smirnova, I., Schupp, I., Boehm, T., Galanos, C., and Freudenberg, M. A. (2001) A point mutation in the IL-12R beta 2 gene underlies the IL-12 unresponsiveness of LPS-defective C57BL/10ScCr mice. J. Immunol. 167, 2106-2111
53. Hohmeier, H. E., Tran, V. V., Chen, G., Gasa, R., and Newgard, C. B. (2003) Inflammatory mechanisms in diabetes: lessons from the beta-cell. Int. J. Obes. Relat. Metab. Disord. 27 (Suppl. 3), S12-S16
54. Johansson, U., Olsson, A., Gabrielsson, S., Nilsson, B., and Korsgren, O. (2003) Inflammatory mediators expressed in human islets of Langerhans: implications for islet transplantation. Biochem. Biophys. Res. Commun. 308, 474-479
55. Weir, G. C., Laybutt, D. R., Kaneto, H., Bonner-Weir, S., and Sharma, A. (2001) Beta-cell adaptation and decompensation during the progression of diabetes. Diabetes 50 (Suppl. 1), S154-S159
56. Davalli, A. M., Scaglia, L., Zangen, D. H., Hollister, J., Bonner-Weir, S., and Weir, G. C. (1996) Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes 45, 1161-1167
57. Campbell, I. L., Iscaro, A., and Harrison, L. C. (1988) IFN-gamma and tumor necrosis factor-alpha. Cytotoxicity to murine islets of Langerhans. J. Immunol. 141, 2325-2329
58. Lamhamedi-Cherradi, S. E., Zheng, S., Tisch, R. M., and Chen, Y. H. (2003) Critical roles of tumor necrosis factor-related apoptosis-inducing ligand in type 1 diabetes. Diabetes 52, 2274-2278
59. Flodstrom, M., and Eizirik, D. L. (1997) Interferon-gamma-induced interferon regulatory factor-1 (IRF-1) expression in rodent and human islet cells precedes nitric oxide production. Endocrinology 138, 2747-2753
60. Grey, S. T., Arvelo, M. B., Hasenkamp, W., Bach, F. H., and Ferran, C. (1999) A20 inhibits cytokine-induced apoptosis and nuclear factor kappaB-dependent gene activation in islets. J. Exp. Med. 190, 1135-1146